Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-03-14
2010-06-01
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S236500, C514S254050, C548S365400, C548S374100, C548S365700, C548S364100, C546S211000, C544S371000, C544S140000
Reexamination Certificate
active
07728029
ABSTRACT:
Provided herein are compounds of the formula (I):as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, type II diabetes mellitus and metabolic syndrome.
REFERENCES:
patent: 4277418 (1981-07-01), Ackermann et al.
patent: 4620865 (1986-11-01), Beck et al.
patent: 4792565 (1988-12-01), Shimotori et al.
patent: 5948777 (1999-09-01), Bender et al.
patent: 6096898 (2000-08-01), Podhorez et al.
patent: 7345058 (2008-03-01), Gillespie et al.
patent: 2001/0044445 (2001-11-01), Bamaung et al.
patent: 2003/0229119 (2003-12-01), Kim et al.
patent: 2004/0220170 (2004-11-01), Atkinson et al.
patent: 2005/0020564 (2005-01-01), Atkinson et al.
patent: 2006/0106052 (2006-05-01), Crooks et al.
patent: 2006/0223852 (2006-10-01), Gillespie et al.
patent: 196 15 976 (1996-04-01), None
patent: 198 53 827 (1998-11-01), None
patent: 0 450 566 (1991-10-01), None
patent: 1 067121 (2001-01-01), None
patent: 1 388 535 (2002-08-01), None
patent: WO 86/02641 (1986-05-01), None
patent: WO 97/11690 (1997-04-01), None
patent: WO 99/31976 (1999-07-01), None
patent: WO 99/67235 (1999-12-01), None
patent: WO 00/27394 (2000-05-01), None
patent: WO 01/05769 (2001-01-01), None
patent: WO 01/14339 (2001-03-01), None
patent: WO 01/29007 (2001-04-01), None
patent: WO 01/46172 (2001-06-01), None
patent: WO 02/44133 (2002-06-01), None
patent: WO 02/064545 (2002-08-01), None
patent: WO 02/064546 (2002-08-01), None
patent: WO 02/064565 (2002-08-01), None
patent: WO 03/028641 (2003-04-01), None
patent: WO 03/037274 (2003-05-01), None
patent: WO 03/051845 (2003-06-01), None
patent: WO 03/070244 (2003-08-01), None
patent: WO 03/093250 (2003-11-01), None
patent: WO 2004/014844 (2004-02-01), None
patent: WO 2004/072034 (2004-08-01), None
patent: WO 2004/089415 (2004-10-01), None
patent: WO 2004/089416 (2004-10-01), None
patent: WO 2004/089470 (2004-10-01), None
patent: WO 2004/089896 (2004-10-01), None
patent: WO 2004/099156 (2004-11-01), None
patent: WO 2005/000793 (2005-01-01), None
patent: WO 2005/009973 (2005-02-01), None
patent: WO 2005/016877 (2005-02-01), None
patent: WO 2005/020897 (2005-03-01), None
patent: WO 2005/048948 (2005-06-01), None
patent: WO 2005/073165 (2005-08-01), None
patent: WO 2005/095357 (2005-10-01), None
patent: WO 2005/110971 (2005-11-01), None
patent: WO 2006/007864 (2006-01-01), None
patent: WO 2006/015860 (2006-02-01), None
patent: WO 2006/031806 (2006-03-01), None
patent: WO 2006/035967 (2006-04-01), None
patent: WO 2006/100502 (2006-09-01), None
patent: WO 2006/106052 (2006-10-01), None
patent: WO 2007/058346 (2007-05-01), None
Schafer et al. Drug Discovery Today 2008, 13 (21/22), 913-916.
Horig et al. Journal of Translational Medicine 2004, 2(44).
Garg, H.G.,J. Med. Chem.(1971) 147), 649-650.
Garg, H.G.,J. Med. Chem.(1979) 22(3), 321-325.
Soliman, R. et al,J. Med. Chem.(1983) 26(11) 1659-1663.
Garg, H.G.,J. Med. Chem.(1968) 11(5), 1103-1104.
Garg, H.G.,J. Med. Chem.(1968) 11(5) 1104-1105.
Kees,K. et al,J. Med. Chem, (1996) 39(20) 3920-3928.
Schroff, J. et al,J. Med. Chem.(1981) 24(12) 1521-1525.
R. A. De FronzoDrugs1999,58 Suppl. 1, 29.
S.E. Inzucchi JAMA 2002, 287, 360.
R.C. Turner et al JAMA 1999, 281, 2005.
M. Tadayyon and S.A. Smith Expert Opin. Investig. Drugs 2003, 12, 307.
Advanced Organic Chemistry [J. March, 3rdEdition, John Wiley & Sons, Inc. New York, 1985] on pp. 437-439, and 823-824.
A. Koziara et al Synth. Commun. 1995, 25, 3805-3812.
A.V. Rama Rao et al. Tetrahedron Lett. 1990, 31, 1439-42.
A.X. Wang et al. Bioorg. Med. Chem. Lett 1998, 8, 2787-2792.
B. Mlotkowska and Z. Zwierzak Tetrahedron Lett. 1978, 19, 4731-4734.
B.R. Walker et al. J. Clin. Endocrinol. Metab. 1995, 80, 3155.
Beck, J. et al., J. Heterocycl. Chem. 1987, 24, 693-695.
C.S. Pak et al. Synthesis 1992, 1213-1214.
Comprehensive Organic Transformations: A Guide to Functional Group Preparations [R. C. Larock, VCH Publishers, Inc. New York, 1989] on pp. 1061-1063.
D.E. Seitz et al Tetrahedron Lett. 1995 36, 1413-1416.
E.S. Ford et al. JAMA 2002, 287, 356.
F.B. Dains Chem. 1902, 35, 2496-2500.
F.B. Dains et al. J. Am. Chem. Soc. 1909, 31, 1148-1157.
F.B. Dains et al. J. Am. Chem. Soc. 1916, 38, 1515.
F.B. Dains et al. J. Am. Chem. Soc. 1918, 40, 562-569.
F. Bondavalli et al. J. Med. Chem. 2002, 45, 4875-4887.
G. Giacomelli et al. Eur. J. Org. Chem. 2003, 537-541.
G. Menozzi et al. J. Heterocycl. Chem. 1987, 24, 1669-1676.
H. Emtenas et al. J. Org. Chem. 2001, 26, 6756-6761.
H.H. Wassermann et al. Tetrahedron Lett. 1984, 25, 3743-3746.
H. Masuzaki et al. Science, 2001, 294, 2166.
H. Ohki et al. Biororg. Med. Chem. Lett 2002, 12, 3191-3193.
H.W. Geluk and J.L.M.A. Schlatmann Tetrahedron 1968, 24, 5369-5377.
J. Fugger et al. J. Am. Chem. Soc. 1955, 77, 1843-1848.
J.H. Dewar et al. J. Chem. Soc. 1961, 3254-3260.
J.R. Beck et al. J. Heterocycl. Chem. 1987, 24, 267-270.
J.R. Beck et al. J. Heterocycl. Chem. 1987, 24, 739-740.
J. Svete et al. Synthesis, 1990, 70-72.
J. Svetlik Heterocycles 1984, 22, 2513-2516.
J. Timberlake and J. Stowell, S. Patai Ed., John Wiley & Sons, Ltd. London 1975, 69-107.
J. Viret et al. Tetrahedron 1987, 43, 891-894.
Jirgensons, A., Kauss, V., Kalvinsh, I., Gould, M.R. Synthesis 2000, 12, 1709-1712.
L.A. Paquette and R.F. Doehner, Jr. J. Org. Chem. 1980, 45, 5105-5113.
L. Claisen Liebigs Ann. Chem. 1897, 297, 1-18.
L. Crombie et al. J. Chem Soc. Perkin Trans. I 1979, 464-471.
L. DeLuca et al. J. Comb. Chem. 2003, 5, 465-471.
L.F. Audrieth and L.H. Diamond J. Am. Chem. Soc. 1954, 76, 4869-4871.
M. Kopp et al J Heterocycl. Chem. 2001, 38, 1045-1050.
M.S. Gibson, S. Patai Ed., John Wiley & Sons, Ltd. London 1968, 37-77.
M.S.S. Palanki et al. J. Med. Chem. 2000, 43, 3995-4004.
M. Salas J.J. and Caro adv. Drug React. Tax Rev. 2002, 21, 205-217.
M.T. Herrero et al. Tetrahedron, 58, 8581-8589 2002.
N. Brosse et al. Tetrahedron Lett. 2000, 41, 205-207.
N.I. Ghali et al. J. Org. Chem. 1981, 46, 5413-5414.
N. J. Cusack et al. J. Chem Soc. C 1971, 1501-1507.
N.M. Morton et al. J. Biol. Chem. 2001, 276, 41293.
O.S. Wolfbeis Chem. Ber. 1981, 114, 3471-3484.
Onodera, G. et al. Organic Letters 2005, 18, 4029.
P. Kocienski et al. Tetrahedron Lett. 1988, 29, 4481-4.
P. Seneci et al. Synth. Commun. 1999, 29, 311-341.
R.A.S. Schweizer et al. Mol. Cell. Endocrinol. 2003, 212, 41.
R.C. Andrews et al. J. Clin. Enocrinol. 2003, 212, 41.
R.C. Larock, VCH Publishers, Inc. New York, 1989 on pp. 421-423.
R.C. Larock, VCH Publishers, Inc. New York, 1989 on pp. 685, 694-695, and 768.
Jones, R. G. et al, J. Am. Chem. Soc. 1952 74, 4889-4891.
R. Kuang, et al, Tetrahedron Lett. 2000, 41, 9575-9579.
R. Zupet et al. J. Heterocycl. Chem. 1991, 28, 1731-1740.
S. Diederich et al. Eur. J. Endocrinol. 2000, 142, 200.
S.E. Inzucchi JAMA 2002, 287, 360.
S. Gelin et al. Synthesis 1983, 566-568.
S. Schenone et al. Bioorg. Med. Chem. Lett. 2001, 11, 2529-2531.
S. Zawadzki et al. Synthesis 1987, 485-487.
Meyer, K. G., Synlett 2004, 2355-2356.
T.A. Elmaati et al. Pol. J. Chem. 2002, 76, 945-952.
T.C. Sandeep et al. Proc. Natl. Acad. Sci USA 2004, 101, 6734.
T. Luebbers et al. Bioorg. Med. Chem. Lett. 2000, 10,821-826.
U. Ragnarsson Che. Soc. Rev. 2001, 30, 205-213.
X-J. Wang and K. Grozinger Tetrahedron Lett. 2000, 41, 4713-4716.
Y. Kotolevtsev et al. Proc. Natl. Acad. Sci. USA 1997, 94, 14924.
Anderson Kevin William
Fotouhi Nader
Gillespie Paul
Goodnow, Jr. Robert Alan
Guertin Kevin Richard
Anderson Rebecca L
Hoffmann-La Roche Inc.
Johnston George W.
Megerditchian Samuel H.
Nolan Jason M
LandOfFree
Adamantyl-pyrazole carboxamides as inhibitors of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adamantyl-pyrazole carboxamides as inhibitors of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adamantyl-pyrazole carboxamides as inhibitors of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4206201